Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products

Human Pluripotent Stem Cell (PSC)-derived cell therapy holds enormous promise because of the cells’ “unlimited” proliferative capacity and the potential to differentiate into any type of cell. However, these features of PSC-derived cell products are associated with concerns regarding the generation...

Full description

Bibliographic Details
Main Authors: Shin Kawamata, Hoshimi Kanemura, Noriko Sakai, Masayo Takahashi, Masahiro J. Go
Format: Article
Language:English
Published: MDPI AG 2015-01-01
Series:Journal of Clinical Medicine
Subjects:
RPE
Online Access:http://www.mdpi.com/2077-0383/4/1/159